Background
The acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by either direct or indirect damage to the lung parenchyma often causing critical hypoxemia and/or hypercapnia [1]. The mortality for ARDS remains high between 30 and 60% despite all the progress made in intensive care during the last decades [2, 3]. The management of this severe disease at specialized intensive care units (ICU) is a resource-consuming process that requires a specially qualified team, a high-technology standard and sophisticated treatment strategies to provide life-sustaining therapy [4]. Healthcare research in the field of critical care medicine is relatively new, and data on the influence of organizational structures or processes of care on mortality or health-related quality of life (HRQoL) in ICU survivors are of growing interest [5, 6]. Not all of these critically ill patients with an ARDS are treated primarily in a specialized center and, thus, eventually experience inter-hospital transfer (IHT).
In Germany, the frequency of IHT has grown considerably in recent years and will steadily increase as a result of the expansion of specialized centers. For example, in the southwestern part of Germany the number of IHTs rose by 9.4% from 2014 to 2015 [7]. As a consequence, the health expenditures for patient transports were increased each year and for Germany overall costs rose to 5.94 million Euros in 2013 [8].
Anzeige
The IHT is a secondary transport from one institution of initial or standard care for further therapy to an institution of advanced and/or maximum care, while maintaining the intensive medical therapy already in progress [9, 10]. In this context, the IHT is synonymous with the term intensive care transport. The decision to transport an ARDS patient is based on an assessment of the potential benefits of transport weighed against the potential risks. The transport must be as safe as possible and should not pose additional risks.
In Germany, IHT is conducted regularly by the authorized organizations of the Emergency Medical Services (EMS) coordinated by the local Emergency Medical Dispatch Center (EMDC). Standard EMS vehicles do not provide special intensive care equipment. ARDS patients require continuous monitoring and expanded intensive medical equipment (e.g., for lung-protective mechanical ventilation) and accordingly staff trained in intensive care medicine. These critically ill patients should be transferred with special vehicles such as intensive care ambulances (ICA) or intensive care helicopters (ICH).
In this study, we assessed the quality of IHT in transport survivor patients suffering from ARDS referred to specialized centers in a Germany-wide multicenter study. In addition to the means of transport used and the transport duration, the qualification of transportation personnel, technical equipment, ventilation parameters and the incidence of critical events were recorded.
Methods
Study design and sample
We observed the quality of IHT in patients with an ARDS in the context of a large Germany-wide prospective cohort study (DACOPO study [11], ClinicalTrials.gov Identifier: NCT02637011). Briefly, the DACAPO study investigates the influence of quality of care and individual patient characteristics on HRQoL and return to work in survivors of ARDS. The study has been approved by the Ethics Committee of the University of Regensburg (original approval: December 2013, approval of an amendment: June 2014; file number 13-101-0262) and (if necessary) by Ethics Committees of the participating study centers. The inclusion criteria for enrollment of patients were the presence of an ARDS according to the Berlin definition [12] and being 18 years of age or older. Written informed consent was obtained from caregivers/legal guardians and additionally from those patients who survived ICU. ARDS patients were included in the study after admittance to one of the participating hospitals, and data on transport were collected retrospectively. Mortality during transportation could thus not be analyzed. Eligible patients were enrolled in 34 receiving hospitals all over Germany in the period from September 2014 to April 2016 (N = 1234). The health status of all transferred patients who had been treated before in a referring hospital was retrospectively assessed for the period of their stay in this hospital and for the period during inter-hospital transport. In the following, the examined aspects of the structural-, process- and outcome-related quality with regard to IHT are explained.
Anzeige
Measures
Sociodemographic and clinical parameters
The following sociodemographic and clinical parameters were assessed: age, body mass index (BMI), distribution of severity of ARDS, cause of ARDS, applied oxygen fraction (FiO2), positive end-expiratory pressure (PEEP), concentration of applied continuous infusion of norepinephrine (noradrenalin), sequential organ failure assessment (SOFA), use and duration for implementation of extracorporeal membrane oxygenation (ECMO) and type of used respirator. The clinical parameters of patients before transport were stated in the morning of the transportation day.
Structural quality of IHT
The structural quality of IHT can be determined on the basis of technical and human resources. In Germany, technical equipment of rescue vehicles is standardized by Germany’s national standards body (DIN norms) and European Committee for Standardization (CEN norms), respectively. The qualification of the EMS staff for IHT is recommended by the provisions of the German Interdisciplinary Association of Critical and Emergency Care Medicine (DIVI: Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin) and German Confederation of Associations of Emergency Physicians (BAND e.V.: Bundesvereinigung der Arbeitsgemeinschaften der Notärzte Deutschlands e.V.) [13].
Technical equipment of EMS vehicles
For transporting patients, specific standards are required. Three types of ambulances for the ground-based EMS vehicles with a minimum of technology standard are available in accordance with CEN 1789:2014-12:
-
Type A: Patient Transport Ambulance
-
Type B: Emergency Ambulance
-
Type C: Mobile Intensive Care Unit
For the airborne transportation of patients, emergency helicopters or ICH are available. The technical standards of medical helicopters are normed by CEN 13718-1:2014 (Medical vehicles and their equipment—Air ambulances—Part 1: Requirements for medical devices used in air ambulances) and CEN 13718-2:2015 (Medical vehicles and their equipment—Air ambulances—Part 2: Operational and technical requirements for air ambulances). In Germany, some helicopters are dedicated to dual use, i.e., these air ambulances can be used in the regular EMS as well as in intensive care transport [14].
Based on these standards, we assessed the following items (yes/no): type of EMS vehicles and problems with technical equipment.
Qualification of transportation staff
For the escorting physician, we assessed the following items (yes/no), based on DIVI recommendations [13, 14]:
1.
Three years of clinical training in a field with intensive care tasks,
2.
Six months verifiable full-time on an ICU,
3.
Qualification as a pre-hospital emergency physician in the EMS according to local regulations,
4.
Attending a 20-h course “intensive care transportation”
1.
Professional qualification: paramedic
2.
At least 3 years in an emergency service in a full-time or a time comparable to professional experience
3.
Attending a 20-h course “intensive transport for emergency services personnel”
Process quality of IHT
The planned and used EMS vehicle, the IHT distance, the duration of the planning of IHT and the actually required duration of IHT were recorded using a specific case report form during patient admission in the receiving hospital and were extracted from the DIVI transport protocols [15, 16]. The communication between the referring and receiving hospital and between referring and transport physician was also registered. In the planning of the study, we decided not to register respirator settings (tidal volume, breathing frequency) or lung-protective ventilation, because these parameters were too variable and not documented in a standardized manner.
Outcome-related quality of IHT
Changes in oxygenation (PaO2/FiO2) and critical events (cardiopulmonary resuscitation, accidental extubation, hypoxia, and hypotension) were considered indicators of the outcome-associated qualities during IHT.
Data collection
The clinical data from the referring clinics were recorded by means of a fax request. Furthermore, communication between physicians of the referring and receiving hospitals was registered. For each transferred patient, 220 up to 295 items were collected from study participants in the receiving hospitals. The collected data were transferred to the online documentation system (OpenClinica®) as comprehensive as possible. In addition, the receiving physicians recorded whether an ARDS was overlooked in patients who were transferred.
Statistical analysis
Extensive plausibility tests were performed to ensure data quality. Due to the explorative character of this study, imputation methods are not appropriate. Thus, the statistical analyses are based on complete data for each parameter. Descriptive statistics were performed by calculating median (Md) and inter-quartile range (IQR) for continuous variables. Counts and percentages were calculated for categorical variables. For inference statistical analyses regarding central tendency, Wilcoxon signed-rank test (dependent samples) and the Mann–Whitney U test (independent samples) were carried out. In the case of categorial data, Fisher’s exact test was used. All tests are two-tailed. The significance level was set at p < 0.05. Analyses were computed using IBM SPSS Statistics (version 24).
Results
A total of 431 patients with an ARDS were transferred from 315 different referring hospitals into 34 different receiving hospitals. Twenty-nine of these 34 hospitals (85%) are members of the German ARDS network. The median treatment time was 4 days (IQR 2–8) in the primary hospital before transportation. In median, six ARDS patients from five different hospitals were transferred per receiving hospital. In addition, the physicians of the receiving hospitals registered in 49 cases that the ARDS has been overlooked in the referring clinic in terms of a missing diagnosis. These 49 cases could not be included in the analysis.
Sociodemographic and clinical parameters
The median age of ARDS patients was 54 years (IQR 43.0–64.0). 272 of the patients (63.1%) were male. In 84%, direct pulmonary injury was the cause of ARDS. This ARDS cohort had a median BMI of 27.8 kg/m2 (IQR 24.7–33.4), and 26.8% were obese with BMI ≥ 30 kg/m2. The patients’ clinical characteristics before and after transportation are shown in Table 1. Particularly, patients with a moderate or severe ARDS were transported. The dose of noradrenalin infusion was stable during the IHT. All patients were mechanically ventilated during transport, predominantly in a pressure-controlled manner (81.3% biphasic positive airway pressure [BIPAP], 10.8% pressure control ventilation [PCV]). The types of respirators used were heterogeneous: the Oxylog 3000 plus (Fa. Dräger®) was most frequently mentioned (39%). The ventilation of the ARDS patients during transport was performed with a median positive end-expiratory pressure (PEEP) of 15 cm H2O under applied FiO2 of 0.9 (median). In total, 52 patients (12.3%) with median age of 52.5 years were transferred while being treated with ECMO. The implantation of ECMO was carried out in the referring hospital (median 60 min before IHT) by specialized ECMO teams.
Table 1
Patient characteristics before and after transport (Wilcoxon test)
Before transporta | After transportb | p value | |
|---|---|---|---|
ARDS severity (n = 295) (according to Berlin definition) | |||
Mild (n/%) | 4/1.3 | 13/4.4 | |
Moderate (n/%) | 69/23.4 | 97/32.9 | |
Severe (n/%) | 222/75.3 | 185/62.7 | |
SOFA score (n = 147) median (IQR) | 10 (8–12) | 11 (8–13) | < 0.001* |
PaO2/FiO2 (mmHg) | |||
All patients (n = 293) median (IQR) | 78.8 (62.9–100) | 82.9 (64.6–121.9) | 0.002* |
Without ECMO (n = 251) median (IQR) | 80.0 (63.3–101.3) | 81.5 (63.8–115.1) | 0.059 |
With ECMO (n = 42) median (IQR) | 72.5 (54.1–92.1) | 95.6 (67.9–131.7) | 0.002* |
Continuous infusion of noradrenalin (µg/kg/min) (n = 173) median (IQR) | 0.22 (0.10–0.59) | 0.24 (0.11–0.59) | 0.388 |
Structural quality of IHT
Technology-related problems of EMS vehicles
In our study, we observed eight technology-related problems. Equipment problems comprised especially the respirator and syringe pump. In three cases a change in EMS vehicle was necessary (Table 2).
Table 2
Frequency of critical events in 431 observed patients
Critical events | Total (n) |
|---|---|
Patient-related | |
Cardiopulmonary resuscitation | 3 |
Accidental extubation | 2 |
Hypoxia (SpO2 < 85% over at least 5 min) | 30 |
Hypotension (systolic blood pressure < 80 mmHg over at least 5 min) | 7 |
Technology-related | |
Equipment problems (thereof: respirator/syringe pump/others) | 5 (3/1/1) |
Transportation vehicle change necessary | 3 |
Transportation delay | |
Occurred transportation delaya (thereof: weather-/staff-related problems/others) | 9 (3/1/5) |
Qualification of transportation staff
The qualification of the transportation staff according to the requirements of the DIVI is summarized in Table 3. All transport teams included a physician. Nearly three-quarter of the physicians attended the intensive transport course.
Table 3
Qualification of transportation staff
Qualification of transportation staff | Results n (%) | Unknown/missing n |
|---|---|---|
Transport physician | ||
3 years of clinical training in a field with intensive care tasks with additional 6 months verifiable full-time in an ICU | 256 of 279 (91.8) | 152 |
Qualification as an EMS physician (according to local regulations) | 226 of 237 (95.4) | 194 |
20-h course “intensive transportation” | 131 of 179 (73.2) | 252 |
→ All DIVI qualifications | 125 of 179 (69.8) | 252 |
Paramedic | ||
≥3 years in an emergency service in a full-time or a time comparable to professional experience | 188 of 190 (99.0) | 241 |
20-h course “intensive transport for emergency services personnel” | 144 of 166 (86.7) | 265 |
→ All DIVI qualifications | 144 of 166 (86.7) | 265 |
Process quality of IHT
Transport characteristics
The median time interval for inter-hospital transport of ARDS patients between request of the referring doctor to the local EMDC and the start of the patient transport was 165 min (IQR 90–290 min). The median time span to organize the IHT was 180 min for airborne and 160 min for ground-based transportation. There were no significant differences in patient characteristics between ground-based and airborne transportation. Over two-thirds of the ARDS patients were transported on the ground; in nearly one-third of all patients an airborne transport was operated. The median distance between the referring and receiving hospitals was 58 km (IQR 23–105 km), and the median transport time was 60 min (IQR 40–90 min). The median duration of transport for patients using ECMO was also 60 min. The median distance and duration for ground-based transportation were 37 km in 60 min compared to 99 km in 54 min for airborne transport. Table 4 compares the transport vehicle requested by the referring institution and the ones actually used. No patient was transferred by EMS vehicle Type A. Transportation delays were caused by weather- and staff-related problems.
Table 4
Characteristics of rescue transport vehicle used (requested and actually used)
Transport vehicle | By referring hospital requested vehicle n (%) | Used vehicle n (%) |
|---|---|---|
Emergency helicopter/Intensive care helicopter | 120 (35.7) | 115 (32.2) |
Intensive care ambulance | 177 (52.7) | 191 (53.5) |
Emergency ambulance (type B/C CEN 1789:2014) | 39 (11.6) | 51 (14.3) |
Total | 336 (100) | 357 (100) |
Unknown/missing | 95 of 431 (22.0) | 74 of 431 (17.2) |
Communication
In 99% (388 of 392 cases, 39 missing data) of transfers, direct communication took place between the referring and receiving hospitals. In four cases the receiving hospital was not aware of the patient allocation before the beginning of IHT. A structured conversation about the patient’s condition between referring and transport physician took place in 99.1% (345 of 348 cases, 83 missing data).
Outcome quality of IHT
For all patients who oxygenation data were available, the median PaO2/FiO2 ratio was significantly better after IHT (p = 0.002) (Table 1). This applies also to patients with ECMO (p = 0.002). Patients with ECMO tended to have a better PaO2/FiO2 ratio after transport than patients without ECMO. A change in the severity of ARDS before and after transport was observed in 76 patients. After transportation only 62.7% had an ARDS classified as “severe” as compared to 75.3% before transportation (Table 1). During transport, 42 patient-related and 8 technology-related critical events (11.6%, 50/431 patients) were observed (Table 2). Neither the qualification of the transportation staff nor the used transport vehicle was associated with the occurrence of critical events (p = 0.14). However, the median PaO2/FiO2 ratio before transport was significantly lower in patients who experienced a critical event during the transport (Md = 68 mmHg vs. Md = 80 mmHg, p = 0.017). The occurrence of hypoxia during IHT (n = 30) was lower in patients under ECMO compared to patients without ECMO [3.8% (2 of 52 cases) vs. 7.4% (28 of 379 cases)].
Discussion
This is the first study reporting data from a large number of ARDS patients, who had to be transferred predominantly to specialized hospitals in Germany. The IHT data of 431 patients were investigated prospectively.
The main results of our study are: (1) in most cases transport of ARDS patients was safe and without serious organ failure; (2) process quality for IHT organization: the elapsed time between the request and the departure of the transport was relatively short (Md = 165 min), median duration of transport was 60 min, 68% ground-based transport; (3) sufficient quality of outcome: critical events were rare, no deterioration of gas exchange, no change in concentration of infused catecholamine; (4) good structural quality: the majority of the IHT staff possessed specific qualifications.
The severity of hypoxemia (PaO2/FiO2 ratio ≤ 100 mmHg) is an important predictor for mortality in ARDS patients [12], and hypoxemia is one of the reasons to transfer a patient into a specialized center. In this study the majority of ARDS patients (85%) were transported to ARDS/ECMO centers for further treatment. Patients with a severe ARDS and potentially reversible respiratory failure may have a better chance to survive when transported to an ECMO center [17‐19].
Warren et al. [20] claimed in their guidelines that all critical care transports ideally should be performed by specially trained professionals and the development of ECMO retrieval teams may lead to a safer transport of ARDS patients to tertiary care centers [21]. In this study the qualification of the transportation staff according to the requirements of the DIVI and BAND was respectable, but physician’s participation on DIVI intensive transportation courses might be improved.
In a populous country like Germany, ARDS patients were transferred in a median of 60 min over a distance of 58 km. In our study, patients were transported mainly earth-bound. The airborne transportation of ARDS patients seems to be faster over longer transport distance, but the time span for organization was longer. The use of ECMO during the transport showed no relevant influence on the duration of transport. In a US study in the State of New York, 17 patients with ECMO were transported in 60 min over a mean distance of 37 km [22]. An Italian mobile ECMO team in Monza transferred 42 patients over 121 km in a mean mission time of 508 min [21]. A Canadian study showed no influence of transport times on hospital mortality [23].
Anzeige
The ventilation settings during IHT could have an influence on patients’ outcome. ARDS patients receiving higher PEEP levels (mean difference of at least 3 cm H2O between groups) had a trend toward improved survival [24]. But high PEEP can conceivably cause ventilator-induced lung injury, pneumothorax or decreased cardiac output. In our study, an oxygen fraction of 0.9 was chosen by the majority presumably to avoid hypoxemia during IHT. PCV for ARDS patients is associated with lower peak airway pressures, a more homogeneous gas distribution, improved patient-ventilator synchrony and earlier liberation from mechanical ventilation compared to volume-controlled ventilation [25, 26]. The use of PCV combined with adequate median PEEP of 15 mbar seems to be an indicator for a good quality of care during IHT.
ECMO treatment for transportation of severely hypoxic patients may allow safe and controlled transport to maximum care institutions. Isgrò et al. [27] showed in a 5-year report of 12 Italian patients with severe ARDS that ECMO effectively enabled high-risk ground transfer, significantly improved the arterial oxygenation and allowed a protective lung ventilation. In a Korean study, 18 patients with ECMO therapy were transferred without ventilation to a specialized center [28]. In our study in 52 patients with severe ARDS ECMO cannulations were performed by specialized teams in the referral hospitals and they were transported to receiving hospitals.
Nevertheless, the transport of critically ill patients remains risky. A large Canadian study [29] as well as Rosenberg et al. [30] showed for critically ill transported patients an increased odds ratio of ICU death relative to patients admitted directly to ICU from the emergency room. In the CESAR trial [31], 81 patients from the ECMO group were transported on mechanical ventilation and 2 of these patients (2.4%) died during transport. In our study we observed 42 patient-related and 8 technology-related critical events (11.8%). This incidence might be relatively low, especially considering the possibility of transfer to specialized ARDS centers. Additionally in another study the rate of adverse events during IHT was reported to be low [32]. In the Netherlands the use of a specialist retrieval team reduced the occurrence of adverse events from 34 to 12.5% [33]. Nevertheless, a severe ARDS with a PaO2/FiO2 ratio < 70 mmHg is associated with an elevated risk for the appearance of critical events during IHT.
Strengths and limitations
Our study has some limitations. First, in patients, where an existing ARDS was not diagnosed by referring hospital, no information was available about the quality of transport. The IHT data were collected Germany-wide by different investigators. Unfortunately, we lack information about the type of ECMO (veno-venous, veno-arterial). Furthermore, due to the complex procedures of obtaining written informed consent, we could only include ARDS patients after transportation to the participating hospitals of the DACAPO study.
Anzeige
The strengths of our study are: a pre-specified protocol and case report forms, data collection in several centers across Germany, all elements of quality (structure-, process-, outcome-associated) were assessed.
Conclusion
The transport of critically ill patients is associated with certain risks. The majority of transport staff in our study was well qualified. The rate of patient- and technology-related critical events was relatively low. The time span between the initiation of the transfer procedure and the realization was good and better than expected. Our data suggest that ECMO is an option to transport patients with a severe ARDS safely to specialized ECMO centers, ideally by trained retrieval teams.
Authors’ contributions
SB, FDS, SuB, MB, CA and TB contributed to conception and design. MD, BG and CK provided administrative support. SB, FDS, SuB, MB, MD, CK, CA and TB helped in provision of study materials or patients. All authors performed data analysis and interpretation and wrote the manuscript. All authors read and approved the final manuscript.
Acknowledgements
We are indebted to all the intensivists and study nurses throughout Germany, who, with great commitment, recruited patients for the DACAPO study (the DACAPO Study Group): Aachen, Aachen University Hospital RWTH Aachen, Department of Anesthesiology (PD Dr. Johannes Bickenbach, Dr. Thorben Beeker, Dr. Tobias Schürholz, Jessica Pezechk); Amberg, Klinikum Amberg, Department for Anaesthesiology (Dr. Jens Schloer); Augsburg, Klinikum Augsburg (Dr. Ulrich Jaschinski, Ilse Kreuzer); Bamberg, Sozialstiftung Bamberg Hospital, Department for Anaesthesiology (Dr. Oliver Kuckein); Berlin, Charité - University Medicine Berlin, Department of Anaesthesiology and Intensive Care Medicine (PD Dr. Steffen Weber-Carstens, Dr. Anton Goldmann, Dr. Stefan Angermair, Krista Stoycheva); Berlin, HELIOS Klinikum Berlin-Buch, Department of Intensive Care Medicine (Prof. Dr. Jörg Brederlau, Nadja Rieckehr, Gabriele Schreiber, Henriette Haennicke); Bielefeld, Ev. Krankenhaus Bielefeld. Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Therapy (Dr. Friedhelm Bach, Dr. Immo Gummelt, Dr. Silke Haas, Catharina Middeke, Dr. Ina Vedder, Marion Klaproth); Bochum, Ruhr University Bochum, Department of Anaesthesiology (Prof. Dr. Michael Adamzik, Dr. Jan Karlik, Dr. Stefan Martini, Luisa Robitzky); Bonn, University Hospital Bonn, Department of Anesthesiology and Intensive Care Medicine (Prof. Dr. Christian Putensen, Dr. Thomas Muders, Ute Lohmer); Bremen, Klinikum Bremen-Mitte, Department of Anesthesiology (Prof. Dr. Rolf Dembinski); Deggendorf, Medical Center, Department of Anaesthesiology and Intensive Care Medicine (Dr. Petra Schäffner, Dr. Petra Wulff-Werner); Dortmund, Klinikum Dortmund, Department of Critical Care Medicine (Elke Landsiedel-Mechenbier, Daniela Nickoleit-Bitzenberger, Ann-Kathrin Silber); Dresden, University Hospital Dresden Carl Gustav Carus, Department of Anesthesiology and Intensive Care Medicine (Prof. Dr. Maximilian Ragaller, Prof. Dr. Marcello Gama de Abreu, Alin Ulbricht, Linda Reisbach); Frankfurt am Main, University Hospital Frankfurt, Department of Anaethesiology, Intensive Care Medicine and Pain Therapy (Prof. Dr. Kai Zacharowski, Prof. Dr. Patrick Meybohm, Karin Pense, Gerhard Schwarzmann, Johannes Reske); Freiburg, University Medical Center Freiburg, Department of Anaesthesiology and Critical Care Medicine Freiburg (Prof. Dr. Alexander Hötzel, Dr. Johannes Kalbhenn); Freising, Klinikum Freising, Department of Anaesthesiology (Dr. Christoph Metz, Dr. Stefan Haschka); Göppingen, Klinik am Eichert, ALB FILS Kliniken, Department of Anaesthesiology and Intensive Care (Dr. Stefan Rauch); Göttingen, University Medical Center, Department of Anaesthesiology, Emergency and Intensive Care Medicine (Prof. Dr. Michael Quintel, Dr. Lars-Olav Harnisch, Dr. Sophie Baumann, Andrea Kernchen); Greifswald, University Medicine Greifswald, Department of Internal Medicine B (Dr. Sigrun Friesecke, Sebastian Maletzki); Hamburg, University Hospital Hamburg-Eppendorf, Department of Intensive Care Medicine, Center of Anesthesiology and Intensive Care Medicine (Prof. Dr. Stefan Kluge, Dr. Olaf Boenisch, Dr. Daniel Frings, Birgit Füllekrug, Dr. Nils Jahn, Dr. Knut Kampe, Grit Ringeis, Brigitte Singer, Dr. Robin Wüstenberg); Hannover, Hannover Medical School, Department of Anaesthesiology and Intensive Care Medicine (Dr. Jörg Ahrens, Dr. Heiner Ruschulte, Dr. Andre Gerdes, Dr. Matthias Groß); Hannover, Hannover Medical School, Department of Respiratory Medicine (Dr. Olaf Wiesner, Aleksandra Bayat-Graw); Heidelberg, University of Heidelberg, Department of Anaesthesiology (Dr. Thorsten Brenner, Dr. Felix Schmitt, Anna Lipinski); Herford, Klinikum Herford, Clinic for Anaesthesiology, Surgical Intensive Care Medicine, Emergency Care Medicine, Pain Management (Prof. Dr. Dietrich Henzler, Dr. Klaas Eickmeyer, Dr. Juliane Krebs, Iris Rodenberg); Homburg, Homburg University Medical Centre, Department of Anaesthesiology, Intensive Care and Pain Medicine (Dr. Heinrich Groesdonk, Kathrin Meiers, Karen Salm, Prof. Dr. Thomas Volk); Ibbenbüren, Ibbenbüren General Hospital, Division of Thoracic Surgery and Lung Support (Prof. Dr. Stefan Fischer, Basam Redwan); Immenstadt, Kempten-Oberallgaeu Hospitals, Clinic for Pneumology, Thoracic Oncology, Sleep- and Respiratory Critical Care (Dr. Martin Schmölz, Dr. Kathrin Schumann-Stoiber, Simone Eberl); Ingolstadt, Klinikum Ingolstadt, Department of Anaesthesiology and Critical Care Medicine (Prof. Dr. Gunther Lenz, Thomas von Wernitz-Keibel, Monika Zackel); Jena, Jena University Hospital, Deptartment of Anesthesiology and Intensive Care Therapy (Dr. Frank Bloos, Dr. Petra Bloos, Anke Braune, Anja Haucke, Almut Noack, Steffi Kolanos, Heike Kuhnsch, Karina Knuhr-Kohlberg); Kassel, Klinikum Kassel, Department of Anaesthesiology (PD Dr. Markus Gehling); Kempten, Klinikum Kempten-Oberallgäu gGmbH, Department for Anesthesia and Operative Intensive Care (Prof. Dr. Mathias Haller, Dr. Anne Sturm, Dr. Jannik Rossenbach); Kiel, University Medical Center Schleswig–Holstein, Campus Kiel, Department of Anesthesiology and Intensive Care Medicine (Dr. Dirk Schädler, Stefanie D’Aria); Köln, Cologne-Merheim Hospital, Department of Pneumology and Critical Care Medicine (Prof. Dr. Christian Karagiannidis, Dr. Stephan Straßmann, Prof. Dr. Wolfram Windisch); Köln, University Hospital of Cologne, Department of Anaesthesiology and Intensive Care Medicine (Prof. Dr. Thorsten Annecke, PD Dr. Holger Herff); Langen, Asklepios Kliniken Langen-Seligenstadt, Department of Anesthesiology and Intensive Care Medicine (Dr. Michael Schütz); Leipzig, University of Leipzig, Department of Anesthesiology and Intensive Care Medicine (PD Dr. Sven Bercker, Hannah Reising, Mandy Dathe, Christian Schlegel); Ludwigsburg, Klinikum Ludwigsburg, Academic Teaching Hospital, University of Heidelberg, Department of Anaesthesiology (Katrin Lichy); Ludwigshafen, Klinikum Ludwigshafen, Department of Anesthesiology and Intensive Care Medicine (Prof. Dr. Wolfgang Zink, Dr. Jana Kötteritzsch); Mainz, University Medical Center Mainz, Department of Anaesthesiology (Dr. Marc Bodenstein, Susanne Mauff, Peter Straub); Magdeburg, Magdeburg University Medical Centre, Department of Anaesthesiology and Intensive Care Medicine (Dr. Christof Strang, Florian Prätsch, Prof. Dr. Thomas Hachenberg); Mannheim, University Medical Center Mannheim, Department of Anaesthesiology and Surgical Intensive Care Medicine (Dr. Thomas Kirschning, Dr. Thomas Friedrich, Dr. Dennis Mangold); Marburg, University Hospital, Department of Anaesthesiology (PD Dr. Caroline Rolfes, Tilo Koch); Mönchengladbach, Kliniken Maria-Hilf GmbH, Department of Cardiology (Dr. Hendrik Haake, Katrin Offermanns); München, Bogenhausen Hospital, Department of Anaesthesiology (Prof. Dr. Patrick Friederich, Dr. Florian Bingold); München, Klinikum Großhadern, Department of Anaesthesiology (Dr. Michael Irlbeck, Prof. Dr. Bernhard Zwissler); München, Klinikum Neuperlach, Städtisches Klinikum München GmbH, Department of Anesthesiology, Critical Care and Pain Medicine (PD Dr. Ines Kaufmann); München, Klinikum rechts der Isar, Department for Anaesthesiology of the Technical University of Munich (Dr. Ralph Bogdanski, Dr. Barbara Kapfer, Dr. Markus Heim, PD Dr. Günther Edenharter); Münster, University Hospital Münster, Department for Anaesthesiology, Intensive Care Medicine and Pain Therapy, (Prof. Dr. Björn Ellger, Daniela Bause); Neumarkt, Kliniken des Landkreises Neumarkt i.d.OPf, Department for Anaesthesiology and Intensive Care Medicine (Dr. Götz Gerresheim); Nürnberg, General Hospital Nuremberg, Paracelsus Medical University, Department of Emergency Medicine and Intensive Care (Dr. Dorothea Muschner, Prof. Dr. Michael Christ, Arnim Geise); Osnabrück, Marienhospital Osnabrück, Department of Anaesthesiology (PD Dr. Martin Beiderlinden, Dr. Thorsten Heuter); Passau, Klinikum Passau, Department for Anaesthesiology (Dr. Alexander Wipfel); Regensburg, Caritas Krankenhaus St. Josef, Department for Anaesthesiology (Dr. Werner Kargl, Dr. Marion Harth, Dr. Christian Englmeier); Regensburg, Regensburg University Hospital, Department of Anaesthesiology, Operative Intensive Care (Prof. Dr. Thomas Bein, Dr. Sebastian Blecha, Dr. Kathrin Thomann-Hackner, Marius Zeder); Stuttgart, Katharinenhospital, Department of Anesthesiology (Dr. Markus Stephan); Traunstein, Klinikum Traunstein, Department of Anaesthesiology (Dr. Martin Glaser); Tübingen, Tübingen University Hospital, Eberhard-Karls University Tübingen, Department of Anaesthesiology and Intensive Care Medicine (PD Dr. Helene Häberle); Ulm, Ulm University, Department of Anesthesiology (Prof. Dr. Hendrik Bracht, Christian Heer, Theresa Mast); Würzburg, University of Würzburg, Department of Anaesthesia and Critical Care (PD Dr. Markus Kredel, PD Dr. Ralf Müllenbach). Further, we are grateful to previous members of the Regensburg DACAPO study team (medical documentation: Phillip Sebök, study physician: Kathrin Thomann-Hackner) and to the members of the Advisory Board of the DACAPO Study: Prof. Dr. Julika Loss, Prof. Dr. Bernhard Graf, Prof. Dr. Michael Leitzmann, Prof. Dr. Michael Pfeifer, Regensburg, Germany.
Anzeige
Competing interests
CK received travel grants and lecture fees and performed consultant services for Maquet, Rastatt, Germany; TB received honoraria for lectures and activities as a member of the advisory board of Novalung, Heilbronn, Germany. All other authors (SB, FDS, SuB, MB, MD, BG and CA) declare no competing interests.
Availability of data and materials
Data are available depending on permission from the original data holders (the two principal investigators (PIs) Christian Apfelbacher and Thomas Bein). Due to data economy and subsequently data protection, only the variables required for the analysis project will be provided.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study has been approved by the Ethics Committee of the University of Regensburg (File Number 13-101-0262) and where necessary by ethics committees of the participating study centers. Written informed consent was obtained from caregivers/legal guardians and additionally from those patients who survived ICU.
Funding
The study is funded by the German Ministry of Education and Research (Bundesministerium für Bildung und Forschung, Funding Number 01GY1340).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.